Epidermal growth factor receptor (EGFr); results of a 6 year follow-up study in operable breast cancer with emphasis on the node negative subgroup
Open Access
- 1 January 1991
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 63 (1) , 146-150
- https://doi.org/10.1038/bjc.1991.30
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Eight-Year Results of a Randomized Clinical Trial Comparing Total Mastectomy and Lumpectomy with or without Irradiation in the Treatment of Breast CancerNew England Journal of Medicine, 1989
- Prediction of Relapse or Survival in Patients with Node-Negative Breast Cancer by DNA Flow CytometryNew England Journal of Medicine, 1989
- Efficacy of Adjuvant Chemotherapy in High-Risk Node-Negative Breast CancerNew England Journal of Medicine, 1989
- A Randomized Clinical Trial Evaluating Tamoxifen in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor–Positive TumorsNew England Journal of Medicine, 1989
- A Randomized Clinical Trial Evaluating Sequential Methotrexate and Fluorouracil in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor-Negative TumorsNew England Journal of Medicine, 1989
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987
- MECHANISM OF ACTION OF ADJUVANT CHEMOTHERAPY IN EARLY BREAST CANCERThe Lancet, 1986
- ADJUVANT CMF CHEMOTHERAPY IN OPERABLE BREAST CANCER: TEN YEARS LATERThe Lancet, 1985
- Epidermal growth factor receptors in human breast cancerBreast Cancer Research and Treatment, 1984
- ŒSTROGEN RECEPTORS AND PROGNOSIS IN EARLY BREAST CANCERThe Lancet, 1979